Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Antares Pharma Inc (ATRS)
  7. Financials

ATRS

Antares Pharma Inc
5.595
0.00 (0.00%)
Upgrade to Real-Time

Antares Pharma Inc. (ATRS) Fundamentals
Antares Pharma Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The company's products include OTREXUP, Elestrin, Gelnique, Makena, and others.
SHARE INFORMATION
Market Cap$ 955,065,067
Shares Outstanding170,852,427
Float166,793,067
Percent Float97.62%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 175,890,670
Latest Fiscal EPS$ 0.00
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions385
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months11,632,035
Institutional Holdings Percent92.1%
Institutional Sold Previous 3 Months13,133,069
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months-
Insider Holdings Percent10.4
Insider Sold Previous 3 Months-
Insider Shares Owned17,670,643
TRADING INFO
52 Week High$ 5.60
52 Week Low$ 3.11
52 Week High Change$ 45.95
21 Day Moving Average$ 5.59
21 Day Extended Moving Average$ 5.5899
50 Day Moving Average$ 5.59
50 Day Extended Moving Average$ 5.5604
200 Day Moving Average$ 4.6107
200 Day Extended Moving Average$ 4.9181
10 Day Average Volume451
20 Day Average Volume291
30 Day Average Volume531
50 Day Average Volume552
Alpha0.012247
Beta1.0314
Standard Deviation0.150855
R20.119014
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ 0.00
21 Day Percent Change0.0%
30 Day Price Change$ 0.00
30 Day Percent Change0.0%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ 0.00
Quarter to Date Percent Change0.0%
180 Day Price Change$ 1.69
180 Day Percent Change43.33%
200 Day Price Change$ 2.10
200 Day Percent Change60.17%
Year to Date Price Change$ 2.02
Year to Date Percent Change56.58%

Antares Pharma Inc. (ATRS) Key Ratios

PROFITABILITY
EBIT Margin31.4%
EBITDA Margin33.5%
Pre-Tax Profit Margin11.3%
Profit Margin Count22.94%
Gross Margin61.5%
Profit Margin TOT22.94%
INCOME STATEMENTS
Revenue$ 176,157,442
Revenue Per Share$ 1.0311
Revenue (3 Years)$ 27.88
Revenue (5 Years)$ 30.83
FINANCIAL STRENGTH
Price to Tangible Book6.20
Total Debt To Equity0.20
Int Coverage20.40
Current Ratio3.10
Leverage Ratio1.50
Quick Ratio2.80
Long Term Debt To Capital0.12
VALUATION MEASURES
PE Ratio25.30
Enterprise Value$ 869,093,228
Price to Sales5.4217
Price to Free Cash97.20
PE High Last 5 Years0.00
Price To Book5.30
Price To Cash Flow31.80
PE Low Last 5 Years0.00
Price to Tangible Book6.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.60
Invoice Turnover4.70
Assets Turnover0.80
Return Assets17.39
Return on Equity27.24
Return on Capital22.57

Antares Pharma Inc. (ATRS) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEORobert F. Apple
Emplyoees203
Last AuditUQ
CIK0001016169
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSSurgical and Medical Instrument Manufacturing(339112)
CONTACT INFO
Address100 Princeton South
Suite 300
Ewing, NJ 8628
Websitehttps://www.antarespharma.com
Facsimile-
Telephone+1 609 359-3020
Emailjhowarth@antarespharma.com


Your Recent History
NASDAQ
ATRS
Antares Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.